173 related articles for article (PubMed ID: 11809607)
21. Two cases of Old World cutaneous leishmaniasis in Australian travelers visiting Morocco.
Stewardson AJ; Leder K; Torresi J; Johnson DF
J Travel Med; 2010; 17(4):278-80. PubMed ID: 20636604
[TBL] [Abstract][Full Text] [Related]
22. Varicella zoster virus meningitis complicating sodium stibogluconate treatment for cutaneous leishmaniasis.
Hartzell JD; Aronson NE; Nagaraja S; Whitman T; Hawkes CA; Wortmann G
Am J Trop Med Hyg; 2006 Apr; 74(4):591-2. PubMed ID: 16606989
[TBL] [Abstract][Full Text] [Related]
23. Clinical treatment of ocular demodecosis by lid scrub with tea tree oil.
Gao YY; Di Pascuale MA; Elizondo A; Tseng SC
Cornea; 2007 Feb; 26(2):136-43. PubMed ID: 17251800
[TBL] [Abstract][Full Text] [Related]
24. Randomized, double-blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis.
Ranawaka RR; Weerakoon HS; de Silva SH
Int J Dermatol; 2015; 54(5):555-63. PubMed ID: 25600472
[TBL] [Abstract][Full Text] [Related]
25. Recurrent cutaneous leishmaniasis: successful treatment with sodium antimony gluconate.
Aram H; el-On J
Cutis; 1986 Mar; 37(3):177-9. PubMed ID: 3007035
[TBL] [Abstract][Full Text] [Related]
26. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
[TBL] [Abstract][Full Text] [Related]
27. Leishmaniasis recidivans treated with sodium stibogluconate.
Schewach-Millet M; Fisher BK; Semah D
Cutis; 1981 Jul; 28(1):67-8, 77, 84 passim. PubMed ID: 6266776
[TBL] [Abstract][Full Text] [Related]
28. [Leishmaniasis in a patient with liver cirrhosis].
de Diego Lorenzo A; Bañares R; Catalina V; García Sánchez A; Barrio J; Clemente G
An Med Interna; 2003 Mar; 20(3):145-7. PubMed ID: 12756901
[TBL] [Abstract][Full Text] [Related]
29. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
[TBL] [Abstract][Full Text] [Related]
30. American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?
Yardley V; Ortuno N; Llanos-Cuentas A; Chappuis F; Doncker SD; Ramirez L; Croft S; Arevalo J; Adaui V; Bermudez H; Decuypere S; Dujardin JC
J Infect Dis; 2006 Oct; 194(8):1168-75. PubMed ID: 16991093
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
[TBL] [Abstract][Full Text] [Related]
32. Fractional ablative carbon dioxide laser followed by topical sodium stibogluconate application: A treatment option for pediatric cutaneous leishmaniasis.
Hilerowicz Y; Koren A; Mashiah J; Katz O; Sprecher E; Artzi O
Pediatr Dermatol; 2018 May; 35(3):366-369. PubMed ID: 29574997
[TBL] [Abstract][Full Text] [Related]
33. Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy.
Melaku Y; Collin SM; Keus K; Gatluak F; Ritmeijer K; Davidson RN
Am J Trop Med Hyg; 2007 Jul; 77(1):89-94. PubMed ID: 17620635
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.
Reithinger R; Mohsen M; Wahid M; Bismullah M; Quinnell RJ; Davies CR; Kolaczinski J; David JR
Clin Infect Dis; 2005 Apr; 40(8):1148-55. PubMed ID: 15791515
[TBL] [Abstract][Full Text] [Related]
35. Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell.
Dar MJ; Din FU; Khan GM
Drug Deliv; 2018 Nov; 25(1):1595-1606. PubMed ID: 30105918
[TBL] [Abstract][Full Text] [Related]
36. Visceral leishmaniasis in a renal transplant recipient: diagnostic and therapeutic problems.
Sharma RK; Jha R; Kumar P; Kher V; Gupta A; Kumar A; Gulati S; Arora P; Murari M; Bhandari M
Am J Nephrol; 1996; 16(4):358-60. PubMed ID: 8739293
[TBL] [Abstract][Full Text] [Related]
37. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
38. Antimony-induced cerebellar ataxia.
Khalil EA; Ahmed AE; Musa AM; Hussein MH
Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
[TBL] [Abstract][Full Text] [Related]
39. A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan.
Mueller M; Balasegaram M; Koummuki Y; Ritmeijer K; Santana MR; Davidson R
J Antimicrob Chemother; 2006 Oct; 58(4):811-5. PubMed ID: 16916865
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate.
Tallab TM; Bahamdam KA; Mirdad S; Johargi H; Mourad MM; Ibrahim K; el Sherbini AH; Karkashan E; Khare AK; Jamal A
Int J Dermatol; 1996 Aug; 35(8):594-7. PubMed ID: 8854166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
